Targeted therapy in refractory thyroid cancer: current achievements and limitations

ISSN： 1479-6694

Source： Future Oncology, Vol.7, Iss.5, 2011-05, pp. : 657-668

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenetics in Medullary Thyroid Cancer: From Pathogenesis to Targeted Therapy

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 3, 2016-08 ,pp. : 275-282

Bentham Science Publishers

Access to resources Recommend Favorite

Endocrine therapy – current benefits and limitations

By Nicholson Robert I. Johnston Stephen R.

Breast Cancer Research and Treatment, Vol. 93, Iss. 4, 2005-10 ,pp. : 3-10

Springer Publishing Company

Access to resources Recommend Favorite

Endocrine therapy – current benefits and limitations

By Nicholson Robert I. Johnston Stephen R.

Breast Cancer Research and Treatment, Vol. 93, Iss. 1, 2005-10 ,pp. : 3-10

Springer Publishing Company

Access to resources Recommend Favorite

Targeted Nanosystems for Cancer Therapy

Current Cancer Therapy Reviews, Vol. 13, Iss. 1, 2017-08 ,pp. : 63-73

Bentham Science Publishers

Access to resources Recommend Favorite

New Targeted Therapies for Anaplastic Thyroid Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 1, 2012-01 ,pp. : 87-93

Bentham Science Publishers

Access to resources Recommend Favorite